Global News

Catalent Pharma launches Catalent Applied Drug Delivery Institute

Monday, October 22, 2012 11:38 AM

Catalent Pharma Solutions, a developer of solutions and advanced drug delivery technologies, has launched its Catalent Applied Drug Delivery Institute.

More... »

Charles River Labs, AZ enter strategic partnership

Monday, October 22, 2012 10:43 AM

AstraZeneca, a global biopharmaceutical company, has selected Charles River Laboratories International, a global provider of research products and services, as its preferred strategic partner for outsourced regulated safety assessment and development DMPK (drug metabolism and pharmacokinetics).

More... »

Venture capital investments decline in dollars and deal volume in Q3 2012

Friday, October 19, 2012 03:26 PM

Venture capitalists invested $6.5 billion in 890 deals in the third quarter of 2012, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

More... »

Resverlogix initiates phase II trial of RVX-208 in pre-diabetes

Friday, October 19, 2012 03:20 PM

Resverlogix, a Canadian clinical stage cardiovascular company, has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabolism.

More... »

Omeros adds two new vice presidents to management team

Friday, October 19, 2012 02:21 PM

Omeros, a Seattle, Wash.-based clinical-stage biopharmaceutical company targeting inflammation, coagulopathies and disorders of the central nervous system, has appointed two new vice presidents: Cathy Melfi, Ph.D. as vice president, regulatory affairs and quality systems, and Albert Yu, M.D., as vice president, clinical development.

More... »

Neurovance closes $7M series A1 round for ADHD drug

Friday, October 19, 2012 12:09 PM

Neurovance, has closed a $7 million series A1 round led by existing investor Novartis Venture Fund to further advance development of EB-1020 for adult attention deficit hyperactivity disorder (ADHD).

More... »

Merck Serono, Auxogyn collaborate on Eeva Test

Friday, October 19, 2012 11:01 AM

Merck Serono, the biopharmaceutical division of Merck, and Auxogyn, a company focused on translating scientific discoveries in early embryo development into clinical tools, have entered into a strategic agreement focused on Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

More... »

SpringFire Laboratory Network adds ReproSource to affiliate laboratories

Friday, October 19, 2012 10:32 AM

SpringFire Laboratory Network, a network of independent, esoteric, high complexity laboratories, has added ReproSource Fertility Diagnostics, a Boston-based clinical laboratory and research organization that provides solutions for fertility testing and education, to its network of affiliate laboratories, which provides specialized testing services to clinical trial sponsors and CROs.

More... »

Danone Research deploys IDBS data and process management platform

Wednesday, October 17, 2012 03:57 PM

IDBS, a provider of innovative data and process management, analytics and modelling software, announced that Danone Research, Center for Specialized Nutrition—a life sciences innovation unit for the development of new product concepts for baby nutrition and medical nutrition—has implemented IDBS’ E-WorkBook.

More... »

MMG, Remedy Health to bolster clinical trial enrollment

Wednesday, October 17, 2012 03:46 PM

MMG, a global health communications company specializing in clinical trial patient recruitment and retention, has formed an exclusive partnership with Remedy Health Media, a health information and technology company, to deliver unique access to a larger pool of qualified potential clinical trial participants.

More... »